CASI Pharmaceuticals

CASI is a biopharmaceutical company focused on the acquisition, development, and commercialization of innovative therapeutics addressing CANCER and other unmet medical needs for the global market, with a focus on China and the U.S. Our mission is to become an integrated biopharmaceutical company with significant market share in China, while establishing partnerships for global development and commercialization. Part of our strategy is to leverage our expertise and resources in North America and China to bring safer, more effective, and/or easier-to-use drugs to patients and to develop them more cost-effectively and faster using our unique dual development approach.
Type
Public
HQ
Rockville, US
Employees
20 (est)
CASI Pharmaceuticals is headquartered in Rockville, US

CASI Pharmaceuticals Locations

Rockville, US
Beijing, CN

CASI Pharmaceuticals Metrics

CASI Pharmaceuticals Summary

Market capitalization

$75.3 M

Closing share price

$1.24
CASI Pharmaceuticals's current market capitalization is $75.3 M.

CASI Pharmaceuticals Financials

CASI Pharmaceuticals's revenue is $47.7 K in FY, 2015 which is 101.09% increase from the previous period.
FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015

Revenue

$1.94 M$669 K$23.7 K$47.7 K

Cost of goods sold

$7.47 K$6.27 K

Gross profit

$16.3 K$41.4 K

Operating income

$-5.74 M$-26.2 M$-7.21 M

Operating expense total

$26.2 M$7.19 M

Interest expense

$10 M

Net Income

$-5.74 M$-26.2 M$-7.21 M

Operating cash flow

$7.08 M$-4.46 M$-5.54 M

    CASI Pharmaceuticals Market Value History

    We estimate that CASI Pharmaceuticals's current employees are approximately 100% male

    CASI Pharmaceuticals News

    CASI Pharmaceuticals Company Life

    You may also be interested in